Supplemental Evidence and Data Request on Measures for Primary Healthcare Spending, 34155 [2023-11252]
Download as PDF
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
Dated: May 22, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–11303 Filed 5–25–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Measures for Primary
Healthcare Spending
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Measures for Primary Healthcare
Spending, which is currently being
conducted by the AHRQ’s Evidencebased Practice Centers (EPC) Program.
Access to published and unpublished
pertinent scientific information will
improve the quality of this review.
DATES: Submission Deadline on or
before June 26, 2023.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A,
Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E53A, Rockville, MD
20857.
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Kelly Carper, Telephone: 301–427–1656
or Email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Measures for Primary
Healthcare Spending. AHRQ is
conducting this technical brief pursuant
to Section 902 of the Public Health
Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to
identifying as many studies as possible
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Measures for Primary
Healthcare Spending, including those
that describe adverse events. The entire
research protocol is available online at:
https://effectivehealthcare.ahrq.gov/
products/primary-healthcare-spending.
This is to notify the public that the
EPC Program would find the following
information on Measures for Primary
Healthcare Spending helpful:
D A list of completed studies that your
organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements: study number, study period,
design, methodology, indication and
diagnosis, proper use instructions,
inclusion and exclusion criteria,
primary and secondary outcomes,
baseline characteristics, number of
patients screened/eligible/enrolled/lost
to follow-up/withdrawn/analyzed,
effectiveness/efficacy, and safety results.
D A list of ongoing studies that your
organization has sponsored for this
indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including a study number, the
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, and primary and secondary
outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this indication and an
index outlining the relevant information
in each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; or
information on indications not included
in the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
34155
https://
www.effectivehealthcare.ahrq.gov/
email-updates.
The technical brief will answer the
following questions. This information is
provided as background. AHRQ is not
requesting that the public provide
answers to these questions.
Guiding Questions
The five questions below guide our
work in synthesizing a description of
research, ongoing efforts, and directions
in measuring primary care spending.
1. What are the definitions, data
sources, and methodologies used to
estimate primary care spending in
published reports?
a. How do these various primary care
spending estimation methods vary by:
i. Relative pros and cons of each
estimation method
ii. Administrative burden
iii. Range of spending estimates
iv. Sensitivity analyses
b. What is the evidence of the
relationship between different primary
care spending estimation methods and
the absolute and relative levels of
primary care spending and health
outcomes including morbidity,
mortality, quality of life, and health
equity?
2. What are the research gaps in
understanding primary care spending
estimation methods based on the
findings of the evidence map?
3. What are considerations for
developing valid and standardized
estimation of primary care spending?
4. What are approaches that health
economists, health services researchers,
payers, health systems, and
policymakers can employ to develop
and implement a standardized measure
of primary care spending and to assess
spending over time, across payers/
populations, and across states?
5. Contextual Questions:
a. Is there any emerging consensus
among experts in the field toward a
standard or preferred method for
assessment of primary care spending?
b. How have policymakers and other
decision makers used primary care
spending measures?
Dated: May 22, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–11252 Filed 5–25–23; 8:45 am]
BILLING CODE 4160–90–P
E:\FR\FM\26MYN1.SGM
26MYN1
Agencies
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Page 34155]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11252]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Measures for Primary
Healthcare Spending
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submissions.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Measures for
Primary Healthcare Spending, which is currently being conducted by the
AHRQ's Evidence-based Practice Centers (EPC) Program. Access to
published and unpublished pertinent scientific information will improve
the quality of this review.
DATES: Submission Deadline on or before June 26, 2023.
ADDRESSES:
Email submissions: [email protected].
Print submissions:
Mailing Address: Center for Evidence and Practice Improvement,
Agency for Healthcare Research and Quality, ATTN: EPC SEADs
Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.): Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: Kelly Carper, Telephone: 301-427-1656
or Email: [email protected].
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Measures for Primary
Healthcare Spending. AHRQ is conducting this technical brief pursuant
to Section 902 of the Public Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Measures for Primary Healthcare Spending, including
those that describe adverse events. The entire research protocol is
available online at: https://effectivehealthcare.ahrq.gov/products/primary-healthcare-spending.
This is to notify the public that the EPC Program would find the
following information on Measures for Primary Healthcare Spending
helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this indication. In the list, please indicate whether
results are available on ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, a summary, including the following elements: study
number, study period, design, methodology, indication and diagnosis,
proper use instructions, inclusion and exclusion criteria, primary and
secondary outcomes, baseline characteristics, number of patients
screened/eligible/enrolled/lost to follow-up/withdrawn/analyzed,
effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including a study number, the study period,
design, methodology, indication and diagnosis, proper use instructions,
inclusion and exclusion criteria, and primary and secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this indication and an index outlining the relevant information in each
submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; or
information on indications not included in the review cannot be used by
the EPC Program. This is a voluntary request for information, and all
costs for complying with this request must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: https://www.effectivehealthcare.ahrq.gov/email-updates.
The technical brief will answer the following questions. This
information is provided as background. AHRQ is not requesting that the
public provide answers to these questions.
Guiding Questions
The five questions below guide our work in synthesizing a
description of research, ongoing efforts, and directions in measuring
primary care spending.
1. What are the definitions, data sources, and methodologies used
to estimate primary care spending in published reports?
a. How do these various primary care spending estimation methods
vary by:
i. Relative pros and cons of each estimation method
ii. Administrative burden
iii. Range of spending estimates
iv. Sensitivity analyses
b. What is the evidence of the relationship between different
primary care spending estimation methods and the absolute and relative
levels of primary care spending and health outcomes including
morbidity, mortality, quality of life, and health equity?
2. What are the research gaps in understanding primary care
spending estimation methods based on the findings of the evidence map?
3. What are considerations for developing valid and standardized
estimation of primary care spending?
4. What are approaches that health economists, health services
researchers, payers, health systems, and policymakers can employ to
develop and implement a standardized measure of primary care spending
and to assess spending over time, across payers/populations, and across
states?
5. Contextual Questions:
a. Is there any emerging consensus among experts in the field
toward a standard or preferred method for assessment of primary care
spending?
b. How have policymakers and other decision makers used primary
care spending measures?
Dated: May 22, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11252 Filed 5-25-23; 8:45 am]
BILLING CODE 4160-90-P